UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is Selective Internal Radioembolization Safe and Effective for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis?

Journal of the American College of Surgeons, 2009-03, Vol.208 (3), p.375-382

2009

Volltextzugriff (PDF)

Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland

Value in health, 2014-11, Vol.17 (7), p.A336-A336

2014

Volltextzugriff (PDF)

Health-Related Quality of Life in Type 1 Diabetes without or with Symptoms of Long-Term Complications

Quality of life research, 2002-08, Vol.11 (5), p.427-436

2002

Volltextzugriff (PDF)

PMU74 FIRST 27 MONTHS OF CONDITIONAL REIMBURSEMENT IN FINLAND

Value in health, 2019-11, Vol.22, p.S721-S721

2019

Volltextzugriff (PDF)

PDB131 THE REAL-WORLD DOSE DIFFERENCES OF INSULIN GLARGINE 300 U/ML IN FINLAND

Value in health, 2019-11, Vol.22, p.S596-S596

2019

Volltextzugriff (PDF)

PCN271 - Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

Value in health, 2016-11, Vol.19 (7), p.A757-A758

2016

Volltextzugriff (PDF)

Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

Value in health, 2016-11, Vol.19 (7), p.A757-A758

2016

Volltextzugriff (PDF)

Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study

Value in health, 2015-11, Vol.18 (7), p.A761-A762

2015

Volltextzugriff (PDF)

PND75 - Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study

Value in health, 2015-11, Vol.18 (7), p.A761-A762

2015

Volltextzugriff (PDF)

Costs of predicting IDDM

Diabetologia, 1998-01, Vol.41 (1), p.79-85

1998

Volltextzugriff (PDF)

PSY62 - Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Value in health, 2015-11, Vol.18 (7), p.A669-A669

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Value in health, 2015-11, Vol.18 (7), p.A609-A609

2015

Volltextzugriff (PDF)

PDB70 - Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Value in health, 2015-11, Vol.18 (7), p.A609-A609

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Value in health, 2015-11, Vol.18 (7), p.A669-A669

2015

Volltextzugriff (PDF)

Experimental and numerical predictions of the ultimate strength of a low-cost composite transtibial prosthesis

Journal of rehabilitation research and development, 2000-07, Vol.37 (4), p.405-413

2000

Volltextzugriff (PDF)

Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?

HPB (Oxford, England), 2011-02, Vol.13 (2), p.91-95

2011

Volltextzugriff (PDF)

PDB27 - Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland

Value in health, 2014-11, Vol.17 (7), p.A336-A336

2014

Volltextzugriff (PDF)

PCV27 COST-EFFECTIVENESS OF BUPROPION IN SMOKING CESSATION IN FINLAND

Value in health, 2004-11, Vol.7 (6), p.693-693

2004

Volltextzugriff (PDF)

PHP19 DRUG PRICE INDICES 1980–2005 IN FINLAND

Value in health, 2006-11, Vol.9 (6), p.A213-A213

2006

Volltextzugriff (PDF)

PHP18 PRICES OF GENERIC DRUGS IN FINLAND VS. EUROPE

Value in health, 2006-11, Vol.9 (6), p.A213-A213

2006

Volltextzugriff (PDF)

PIN43 ADAPTATION OF A HEALTH ECONOMIC MODEL OF THE NATURAL HISTORY OF HPV INFECTION AND CERVICAL CANCER IN A WELL FUNCTIONING POPULATION-BASED SCREENING SYSTEM—A MODEL CALIBRATION TO FINLAND

Value in health, 2007, Vol.10 (6), p.A449-A449

2007

Volltextzugriff (PDF)

PIN42 EVALUATING THE CLINICAL EFFECTS AND THE COST-EFFECTIVENESS OF PROPHYLACTIC CERVICAL CANCER VACCINATION WITHIN AN ORGANISED POPULATION-BASED SCREENING SETTING—CASE FINLAND

Value in health, 2007, Vol.10 (6), p.A449-A449

2007

Volltextzugriff (PDF)

PHP1 RETAIL PRICES DECREASED 30% IN FINLAND IN 1994-2003 EVEN BEFORE INTRODUCTION OF GENERIC SUBSTITUTIONS COHORT ANALYSIS

Value in health, 2004-11, Vol.7 (6), p.708-709

2004

Volltextzugriff (PDF)

PHP6 DRUG PRICE INDICES 1980-2004 IN FINLAND

Value in health, 2005-11, Vol.8 (6), p.A182-A183

2005

Volltextzugriff (PDF)

Comparison of Endoscopic Nd: YAG Laser Therapy and Oesophageal Tube in Palliation of Oesophagogastric Malignancy

Scandinavian journal of gastroenterology, 1991, Vol.26 (1), p.103-108

1991

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Is Selective Internal Radioembolization Safe and Effective for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis?

Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland

Health-Related Quality of Life in Type 1 Diabetes without or with Symptoms of Long-Term Complications

PMU74 FIRST 27 MONTHS OF CONDITIONAL REIMBURSEMENT IN FINLAND

PDB131 THE REAL-WORLD DOSE DIFFERENCES OF INSULIN GLARGINE 300 U/ML IN FINLAND

PCN271 - Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

Trend Towards Longer Time to Reimbursement in Oncological Medicines in Finland 2005-2015

Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study

PND75 - Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study

Costs of predicting IDDM

PSY62 - Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

PDB70 - Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

Experimental and numerical predictions of the ultimate strength of a low-cost composite transtibial prosthesis

Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?

PDB27 - Uses of Electronic Patient Information Systems and National Registers – Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland

PCV27 COST-EFFECTIVENESS OF BUPROPION IN SMOKING CESSATION IN FINLAND

PHP19 DRUG PRICE INDICES 1980–2005 IN FINLAND

PHP18 PRICES OF GENERIC DRUGS IN FINLAND VS. EUROPE

PIN43 ADAPTATION OF A HEALTH ECONOMIC MODEL OF THE NATURAL HISTORY OF HPV INFECTION AND CERVICAL CANCER IN A WELL FUNCTIONING POPULATION-BASED SCREENING SYSTEM—A MODEL CALIBRATION TO FINLAND

PIN42 EVALUATING THE CLINICAL EFFECTS AND THE COST-EFFECTIVENESS OF PROPHYLACTIC CERVICAL CANCER VACCINATION WITHIN AN ORGANISED POPULATION-BASED SCREENING SETTING—CASE FINLAND

PHP1 RETAIL PRICES DECREASED 30% IN FINLAND IN 1994-2003 EVEN BEFORE INTRODUCTION OF GENERIC SUBSTITUTIONS COHORT ANALYSIS

PHP6 DRUG PRICE INDICES 1980-2004 IN FINLAND

Comparison of Endoscopic Nd: YAG Laser Therapy and Oesophageal Tube in Palliation of Oesophagogastric Malignancy

Suchergebnisse filtern